(OCUL) |
| 0 (0%) 04-14 05:00 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.97 |
| Resistance 1: | 10.25 |
| Pivot price: | 8.31 |
| Support 1: | 8.48 |
| Support 2: | 7.39 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.420 |
| Book Value | 3.030 |
| PEG Ratio | 0.00 |
| Gross Profit | -0.697 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -526.49 |
| Return on Assets (ttm) | -26.7 |
| Return on Equity (ttm) | -54.8 |
Company news
Mon, 13 Apr 2026
Large Ocular Therapeutix (OCUL) share gift to spouse disclosed - Stock Titan
Mon, 13 Apr 2026
William Blair Maintains Ocular Therapeutix(OCUL.US) With Buy Rating - Moomoo
Mon, 13 Apr 2026
OCUL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $21 - GuruFocus
Mon, 13 Apr 2026
What's Going On With Ocular Therapeutix Stock Monday? - Ocular Therapeutix (NASDAQ:OCUL) - Benzinga
Mon, 13 Apr 2026
Positive Week 52 Data Released for Ocular Therapeutix (OCUL) - GuruFocus
Mon, 13 Apr 2026
Is Ocular Therapeutix (OCUL) Quietly Recasting Its Retinal Strategy Around Axpaxli’s Phase 3 Design Choices? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
